Carregant...
Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits
OBJECTIVES: Value‐based pricing of oncology drugs provides a best estimate for the price of a drug, as it relates to the benefits it provides for individual patients. To date, the impact of value‐based pricing to reference cost‐effectiveness thresholds (λ) on individual and population‐level health b...
Guardat en:
| Publicat a: | Cancer Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6943176/ https://ncbi.nlm.nih.gov/pubmed/31711274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2694 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|